Your browser doesn't support javascript.
loading
Loss of Cirbp expression is correlated with the malignant progression and poor prognosis in nasopharyngeal carcinoma.
Lin, Tao-Yan; Chen, Yan; Jia, Jun-Shuang; Zhou, Chen; Lian, Mei; Wen, Yue-Ting; Li, Xiao-Yan; Chen, Heng-Wei; Lin, Xiao-Lin; Zhang, Xiao-Ling; Xiao, Sheng-Jun; Sun, Yan; Xiao, Dong.
Afiliación
  • Lin TY; Guangdong Provincial Key Laboratory of Cancer Immunotherapy Research and Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, Southern Medical University, Guangzhou 510515, People's Republic of China.
  • Chen Y; Guangdong Provincial Key Laboratory of Cancer Immunotherapy Research and Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, Southern Medical University, Guangzhou 510515, People's Republic of China.
  • Jia JS; Guangdong Provincial Key Laboratory of Cancer Immunotherapy Research and Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, Southern Medical University, Guangzhou 510515, People's Republic of China.
  • Zhou C; Department of Pathology, The Second Affiliated Hospital, Guilin Medical University, Guilin 541199, People's Republic of China.
  • Lian M; Institute of Comparative Medicine and Laboratory Animal Center, Southern Medical University, Guangzhou 510515, People's Republic of China.
  • Wen YT; Guangdong Provincial Key Laboratory of Cancer Immunotherapy Research and Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, Southern Medical University, Guangzhou 510515, People's Republic of China.
  • Li XY; Institute of Comparative Medicine and Laboratory Animal Center, Southern Medical University, Guangzhou 510515, People's Republic of China.
  • Chen HW; Institute of Comparative Medicine and Laboratory Animal Center, Southern Medical University, Guangzhou 510515, People's Republic of China.
  • Lin XL; Guangdong Provincial Key Laboratory of Cancer Immunotherapy Research and Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, Southern Medical University, Guangzhou 510515, People's Republic of China.
  • Zhang XL; Department of Physiology, Faculty of Basic Medical Sciences, Guilin Medical University, Guilin 541004, People's Republic of China.
  • Xiao SJ; Department of Pathology, The Second Affiliated Hospital, Guilin Medical University, Guilin 541199, People's Republic of China.
  • Sun Y; Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, People's Republic of China.
  • Xiao D; Guangdong Provincial Key Laboratory of Cancer Immunotherapy Research and Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, Southern Medical University, Guangzhou 510515, People's Republic of China.
Cancer Manag Res ; 11: 6959-6969, 2019.
Article en En | MEDLINE | ID: mdl-31413636
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Manag Res Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Manag Res Año: 2019 Tipo del documento: Article